Tenet Reports Results for the Second Quarter Ended June 30, 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Tenet Healthcare (THC) PT Lowered to $24 at Jefferies
August 8, 2017 8:21 AM EDTJefferies lowered its price target on Tenet Healthcare (NYSE: THC) to $24.00 (from $26.00) while maintaining a Buy rating. While THC's Q2 results came in slightly below consensus, analyst Brian Tanquilut views the revenue and EBITDA shortfalls as modest relative to expectations baked into the... More
